← News
Sep 17, 2026 Definitions
Definition Day: DT120
One term worth slowing down on today, straight off yesterday's news.
DT120: Definium Therapeutics' lead LSD candidate — lysergide delivered as an orally-disintegrating tablet, rather than the traditional blotter or liquid form. It was developed under the code name MM120 before the company's January 2026 rebrand from MindMed to Definium. DT120 has now posted two independent positive Phase 3 trials for generalized anxiety disorder — Voyage and Panorama — making it the most advanced LSD program in clinical development, though it's still not FDA-approved for anything.
Full entry, plus 157 other terms, is in our Encyclopedia.